These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 11336685)
21. Regulatory B cells in autoimmune diseases: how do they work? Lemoine S; Morva A; Youinou P; Jamin C Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160 [TBL] [Abstract][Full Text] [Related]
22. [The role of regulatory T cells in the development of autoimmune process in multiple sclerosis]. Eliseeva DD; Zavalishin IA; Karaulov AV; Bykovskaia SN Vestn Ross Akad Med Nauk; 2012; (3):68-74. PubMed ID: 22712278 [TBL] [Abstract][Full Text] [Related]
23. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Fowell D; McKnight AJ; Powrie F; Dyke R; Mason D Immunol Rev; 1991 Oct; 123():37-64. PubMed ID: 1684782 [No Abstract] [Full Text] [Related]
24. A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene. Li Z; Yang N; Zhou L; Gu P; Wang H; Zhou Y; Zhou P; Lu L; Chou KY Immunology; 2016 Mar; 147(3):355-66. PubMed ID: 26694804 [TBL] [Abstract][Full Text] [Related]
25. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. Foussat A; Cottrez F; Brun V; Fournier N; Breittmayer JP; Groux H J Immunol; 2003 Nov; 171(10):5018-26. PubMed ID: 14607898 [TBL] [Abstract][Full Text] [Related]
26. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185 [TBL] [Abstract][Full Text] [Related]
27. The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells. Yi H; Zhang J; Zhao Y Transpl Immunol; 2008 Apr; 19(1):37-44. PubMed ID: 18346636 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease. Haribhai D; Chatila TA; Williams CB Methods Mol Biol; 2016; 1422():197-211. PubMed ID: 27246035 [TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model. Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800 [TBL] [Abstract][Full Text] [Related]
36. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells. Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928 [TBL] [Abstract][Full Text] [Related]
38. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Read S; Powrie F Curr Protoc Immunol; 2001 May; Chapter 15():Unit 15.13. PubMed ID: 18432730 [TBL] [Abstract][Full Text] [Related]
39. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110 [TBL] [Abstract][Full Text] [Related]
40. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease. Bluestone JA; Trotta E; Xu D Expert Opin Ther Targets; 2015; 19(8):1091-103. PubMed ID: 25881491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]